Abrocitinib selectively inhibits Janus kinase 1 (JAK1), reducing pro-inflammatory cytokine signalling (1). Managing chronic inflammatory skin conditions such as atopic dermatitis and psoriasis requires careful attention to symptom control, medication adherence, and patient support (1). Abrocitinib provides a therapeutic option that reduces inflamma
365 Reached1 Comments
Rubella Syndrome in Neonate
1401 Reached12 Comments9 Likes
Use of Clindamycin for Managing Bacterial Vaginosis
11217 Reached29 Comments8 Likes
Black Lesion in Old Female
1974 Reached5 Comments11 Likes
Chronic Hyperplastic Candidiasis Of The Oral Mucosa
858 Reached9 Comments11 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes